SOPHiA GENETICS SA (SOPH) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. KNX
10. ELV

Go back to SOPHiA GENETICS SA (SOPH) Reports In-Line Q3 EPS

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022

November 8, 2022 6:59 AM EST

BOSTON and LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the third quarter ended September 30, 2022.

Recent Highlights

Revenue for the third quarter of 2022 was $11.6 million, representing year-over-year growth of 12%; constant currency revenue growth excluding COVID-19-related revenues was 40%Expanded strategic partnership with Microsoft to improve healthcare workflows globally and enable the increased adoption of data-driven medicineSomatic Oncology portfolio strength underscored by triple-digit growth in HRD analysis... More